Medical Marijuana - Reports
07/13/12 | Exploring the Ecological Association between Crime and Medical Marijuana Dispensaries

Applying the "routine activities theory" of crime, this NIDA-funded study used data from 95 census tracts in Sacramento to analyze two types of crime (violent and property) in areas with varying concentrations of dispensaries. Results indicated that while factors traditionally understood to lead to increased crime ��� large percentages of land zoned for commercial rather than residential use, a high percentage of one-person households, the presence of highway ramps, a higher percentage of the population being ages 15-24 ��� were positively associated with crime in those areas, the density of medical marijuana dispensaries was not associated with violent or property crime rates. In their conclusion, the researchers theorize that measures dispensaries take to reduce crime (i.e., doormen, video cameras) may increase guardianship, thus deterring crime.


07/13/12 | Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer

This analysis of the anti-cancer properties of cannabidiol, a non-psychoactive constituent of marijuana, studied its effect on mice and found that it reduced polyps, tumors, and other carcinogenic precursors, and in colorectal carcinoma cell lines, "protected DNA from oxidative damage, increased endocannabinoid levels and reduced cell proliferation," leading the authors to conclude that cannabidiol does exert a chemopreventive effect.


07/13/12 | Cannabinergic Pain Medicine: A Concise Clinical Primer and Survey of Randomized-controlled Trial Results

This meta-analysis of 38 other randomized-controlled trials that studied the use of cannabis based treatments found that, of these, 27 (71%) "concluded that cannabinoids had empirically demonstrable and statistically significant pain-relieving effects" while 11 (29%) did not.


07/13/12 | Cannabidiol enhances anandamide signaling and alleviates psychotic symptoms of schizophrenia

This double-blind, randomized trial compared the effects of cannabidiol, a non-psychoactive constituent of marijuana, to amisulpride, a potent antipsychotic, in treatment of acute schizophrenia. Results showed that both treatments were safe and effective, but treatment by cannabidiol involved a much safer side-effect profile and presented greater evidence of long-term clinical improvement.


07/13/12 | Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial

This placebo-controlled, crossover study on the effects of smoked marijuana on spasticity, a common and difficult to treat symptom of multiple sclerosis, found that marijuana was significantly more effective than placebo at both reducing muscle spasticity and patients' pain sensations.


01/17/12 | State-By-State Laws Report, 2011

State-By-State Laws Report, 2011


09/07/11 | State Medical Marijuana Programs' Financial Information


08/17/11 | Medical Marijuana and Civil Protections


08/16/11 | The Sixteen States and One Federal District With Effective Medical Marijuana Laws

17 Laws Summary


08/16/11 | Key Aspects of State and D.C. Medical Marijuana Laws


07/28/11 | Federal Enforcement Policy De-Prioritizing Medical Marijuana


07/28/11 | Potential Objections to Medical Marijuana


07/28/11 | Medical Marijuana Endorsements and Statements of Support


07/28/11 | Federal Obstruction of Medical Marijuana Research Memo


07/28/11 | The FDA and Medical Marijuana


07/28/11 | Medical Marijuana and HIV/AIDS


07/28/11 | Effective Arguments for Medical Marijuana Advocates


01/26/10 | Medical Marijuana Briefing Paper - 2011

Medical marijuana briefing paper from the Marijuana Policy Project (2011)


09/25/09 | Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical Trial

This study of marijuana and HIV-related neuropathy arguably closes the case regarding one important indication for medical marijuana: neuropathic pain.


09/25/09 | Vaporization as a Smokeless Cannabis Delivery System: A Pilot Study

Vaporization methods heat marijuana and release cannabinoids, the therapeutically active components of marijuana, in the form of vapor -- without combustion and associated noxious byproducts.


 

Items 1 - 20 of 62  1234Next